Core Viewpoint - *ST HuKe is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure, which adds to the company's existing delisting risk [2][4]. Group 1: Company Status - As of December 12, *ST HuKe's stock price was 3.81 yuan, with a market capitalization of 1.253 billion yuan, reflecting a decline of 0.26% [4]. - The company has been facing delisting risks since April 30, when its stock was flagged due to negative audited profit totals and revenues below 300 million yuan [6]. - The company reported a significant decline in operating scale, with revenues dropping from 367 million yuan in 2022 to 17 million yuan in 2024 [4][6]. Group 2: Financial Performance - The company is projected to incur continuous losses, with net profits of -22.015 million yuan in 2023 and -5.6828 million yuan in 2024 [4]. - For the first three quarters of 2025, *ST HuKe's revenue was only 5.4403 million yuan, representing a year-on-year decline of 63.70%, with a non-recurring net profit of -237,200 yuan [6]. - The decline in revenue is attributed to decreased income from both chemical and agricultural product trading, as well as increased contract penalties in the agricultural sector [6].
*ST沪科被证监会立案